(19)
(11) EP 4 580 654 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23861046.3

(22) Date of filing: 05.07.2023
(51) International Patent Classification (IPC): 
A61K 38/45(2006.01)
C07K 7/06(2006.01)
C12N 9/48(2006.01)
A61K 38/43(2006.01)
A61K 47/64(2017.01)
C12N 9/64(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/64; A61K 47/65; A61K 49/0056; A61K 49/0032; A61K 47/6811; C07K 2319/33; C12N 9/1044; C12Y 203/02013; A61K 38/00; C07K 14/415
(86) International application number:
PCT/US2023/026914
(87) International publication number:
WO 2024/049543 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2022 US 202263373947 P
09.12.2022 US 202263431570 P

(71) Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Stanford, CA 94305-2038 (US)

(72) Inventors:
  • KHOSLA, Chaitan
    Stanford, California 94305 (US)
  • LOPPINET, Elise
    Redwood City, California 94063 (US)
  • BESSER, Harrison
    Palo Alto, California 94301 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMPOSITIONS AND METHODS FOR TRANSGLUTAMINASE-MEDIATED ENDOCYTOSIS